Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated Jun 27, 2024, titled "Communication from United States Food and Drug Administration (USFDA)".
Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated Jun 27, 2024, titled "Communication from United States Food and Drug Administration (USFDA)".